Logo Logo
Help
Contact
Switch language to German
Therapeutic RIG-I activation enhances survival and induces sensitivity to immune checkpoint blockade therapy in preclinical models of AML
Therapeutic RIG-I activation enhances survival and induces sensitivity to immune checkpoint blockade therapy in preclinical models of AML
Not available
AML, Immuntherapie, Triphosphat-RNA
Ruzicka, Michael
2023
English
Universitätsbibliothek der Ludwig-Maximilians-Universität München
Ruzicka, Michael (2023): Therapeutic RIG-I activation enhances survival and induces sensitivity to immune checkpoint blockade therapy in preclinical models of AML. Dissertation, LMU München: Faculty of Medicine
[thumbnail of Ruzicka_Michael.pdf]
Preview
PDF
Ruzicka_Michael.pdf

2MB